[{"status": "Completed", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077651"], "brand_name": ["ZONISAMIDE"], "generic_name": ["ZONISAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-128", "68462-129", "68462-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZONISAMIDE"], "rxcui": ["314285", "403966", "403967"], "spl_id": ["c00ccc2d-52c6-4a11-a310-d8db25ca3928"], "spl_set_id": ["fe15e56e-8b86-4a65-825c-31d37dd81612"], "package_ndc": ["68462-128-01", "68462-128-05", "68462-129-01", "68462-129-05", "68462-130-01", "68462-130-05"], "is_original_packager": [true], "upc": ["0368462130018", "0368462129012", "0368462128015"], "nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["459384H98V"]}, "product_type": "Drugs", "event_id": "90029", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0791-2022", "product_description": "Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01", "product_quantity": "11,136 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220425", "center_classification_date": "20220427", "report_date": "20220504", "code_info": "Lot #: 29200052, Exp 4/30/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Manalapan", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89554", "recalling_firm": "Tsm Brands LLC", "address_1": "540 Equinox Ln", "address_2": "", "postal_code": "07726-8877", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0636-2022", "product_description": "Luxury 70% Isopropyl Alcohol, 16 FL. OZ. (1PT) 473 ML bottle, Distributed by: TSM Brands LLC, 540 Equinox Ln, Manalapan, NJ 07726, UPC 868275965734.", "product_quantity": "135.444 bottles", "reason_for_recall": "Labeling - product contains undeclared ethyl alcohol", "recall_initiation_date": "20220207", "center_classification_date": "20220225", "report_date": "20220309", "code_info": "Lot#:339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,396,397,398 and 399", "more_code_info": ""}, {"status": "Terminated", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90481", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one wholesaler in AL for further distribution in the US.", "recall_number": "D-1188-2022", "product_description": "Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01", "product_quantity": "", "reason_for_recall": "Labeling: Label Mix-up:  bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.", "recall_initiation_date": "20220617", "center_classification_date": "20220708", "termination_date": "20240402", "report_date": "20220720", "code_info": "Lot #: 179643, Exp. Date 08/31/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90569", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1285-2022", "product_description": "Aripiprazole Tablets, USP 20 mg,  packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326", "product_quantity": "2010 bottles", "reason_for_recall": "Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.", "recall_initiation_date": "20220707", "center_classification_date": "20220721", "termination_date": "20250922", "report_date": "20220727", "code_info": "Lots: a) TD9591 Exp. 04/2023; b) TD9592 Exp. 04/2023"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA072741"], "brand_name": ["LOPERAMIDE HYDROCHLORIDE"], "generic_name": ["LOPERAMIDE HYDROCHLORIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-2100"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOPERAMIDE HYDROCHLORIDE"], "rxcui": ["978006"], "spl_id": ["84c39323-d4c3-452c-b89d-d104dcac4346"], "spl_set_id": ["72a7ae47-cdf3-4949-b9f8-f29b153f787f"], "package_ndc": ["0378-2100-01", "0378-2100-05"], "is_original_packager": [true], "unii": ["77TI35393C"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1092-2022", "product_description": "Loperamide Hydrochloride capsules, USP, 2 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-2100-01", "product_quantity": "1 bottle/100 capsules", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0486-2022", "product_description": "Cold/Sinus Pain Reliever/Fever Reducer Nasal Decongestant (acetaminophen 325 mg, Phenylephrine HCl 5mg), 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040", "product_quantity": "301,650 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: K9708, Exp. Date 07/2022"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1416-2022", "product_description": "MYLANTA MAX STRENGTH CLASSIC FLVR 12 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 999844", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065053"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-614", "63304-615", "63304-616"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE"], "rxcui": ["700408", "1649401", "1649990"], "spl_id": ["338488d1-e9d8-6b00-e063-6294a90a37c0"], "spl_set_id": ["829dbd3d-5c2b-47b8-96a5-423af78c93b9"], "package_ndc": ["63304-614-20", "63304-614-05", "63304-614-01", "63304-614-13", "63304-615-05", "63304-615-11", "63304-615-01", "63304-616-20", "63304-616-05", "63304-616-01", "63304-616-13", "63304-616-50"], "is_original_packager": [true], "upc": ["0363304614015"], "nui": ["N0000175882", "N0000007948"], "pharm_class_epc": ["Tetracycline-class Drug [EPC]"], "pharm_class_cs": ["Tetracyclines [Chemical/Ingredient]"], "unii": ["N12000U13O"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1032-2022", "product_description": "Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50", "product_quantity": "3 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0494-2022", "product_description": "PAINAID PMF Premenstrual Formula (acetaminophen 500 mg, pamabrom 25mg) 2 caplet packets, Dist. by ZEE Medical Distributors, LLC Mason, OH 45040, NDC 42961-0046-03", "product_quantity": "769,200 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9434, (L)101, Exp. date 01/2022"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89924", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "IL", "recall_number": "D-0768-2022", "product_description": "Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED Pharmaceuticals, Inc., The Physician's Solution, NDC 68788-7768-01", "product_quantity": "1568 bottles", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.", "recall_initiation_date": "20220323", "center_classification_date": "20220414", "termination_date": "20230504", "report_date": "20220420", "code_info": "Lot #: A0721O, A1421Y, A2121G, A2821D, B0421H, B0421I, B0521U, B1121G, B1921C, C0421B, C1821N, L0120F, L2320O, L3020T, Exp.: 4/30/2022; B2521A, C1121S, C2521U, D0121S, D0921B, D1421B, D2921C, E0721A, Exp.: 10/31/2022; D2221A, Exp.: 12/31/2022"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0914-2022", "product_description": "Ultratest Testosterone Cypionate 160 mg/mL Testosterone Propionate 40 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0058-10", "product_quantity": "520 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: J24014, J24114 BUD: 10/14/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1108-2022", "product_description": "Tropicamide Ophthalmic Solution, USP 1%, 3 mL bottle, Rx only,  MFG: Sandoz Pharma, NDC 6131435502", "product_quantity": "31 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1267-2022", "product_description": "Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) syringe, packaged in 5 x 2 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172,  NDC: 69374-979-02", "product_quantity": "43,385 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: MS2001A, Exp. 7/2/2022; MS2006A, Exp. 8/9/2022; MS2009A, Exp. 8/25/2022; MS2011A, Exp. 9/3/2022; MS2017A, Exp. 10/2/2022"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204021"], "brand_name": ["OXYCODONE HYDROCHLORIDE"], "generic_name": ["OXYCODONE HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-430", "43386-432", "43386-433", "43386-434", "43386-431"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYCODONE HYDROCHLORIDE"], "rxcui": ["1049611", "1049618", "1049621", "1049683", "1049686"], "spl_id": ["78c8a4dc-d475-41ca-acf7-9078e9c36c7f"], "spl_set_id": ["801cb437-c189-44f5-83eb-a51c365d8a6b"], "package_ndc": ["43386-432-01", "43386-432-03", "43386-432-05", "43386-433-01", "43386-433-03", "43386-433-05", "43386-430-01", "43386-430-05", "43386-430-03", "43386-434-01", "43386-434-05", "43386-434-03", "43386-431-01", "43386-431-03", "43386-431-05"], "is_original_packager": [true], "upc": ["0343386434015", "0343386434039", "0343386430031", "0343386432059", "0343386431052", "0343386430017", "0343386433032", "0343386433018", "0343386431038", "0343386432011", "0343386432035", "0343386431014"], "unii": ["C1ENJ2TE6C"]}, "product_type": "Drugs", "event_id": "89324", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed in NY and OH.", "recall_number": "D-0358-2022", "product_description": "Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01", "product_quantity": "23,965 100 count bottles", "reason_for_recall": "Out-of-specification impurity test result observed at 18-month long term stability time point.", "recall_initiation_date": "20211229", "center_classification_date": "20220105", "termination_date": "20220823", "report_date": "20220112", "code_info": "Lot # S000268, Exp. date January 2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89802", "recalling_firm": "Best Brands Consumer Products, Inc.", "address_1": "20 W 33rd St", "address_2": "N/A", "postal_code": "10001-3305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0876-2022", "product_description": "Mickey Mouse Hand Sanitizer, ethyl alcohol 68%, 2.11 oz./to mL bottle, Best Brands Consumer Products, Inc., c/o Best Brands Sales Company LLC, New York, NY NDC 74530-013-02", "product_quantity": "44,640 bottles", "reason_for_recall": "Chemical Contamination; FDA analysis found product to contain methanol", "recall_initiation_date": "20220329", "center_classification_date": "20220517", "termination_date": "20250312", "report_date": "20220511", "code_info": "Lot # 20D21, exp. date 06/30/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA006488"], "brand_name": ["XYLOCAINE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-481", "63323-492", "63323-491", "63323-495", "63323-485", "63323-486", "63323-484", "63323-489", "63323-488", "63323-483", "63323-482", "63323-487"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1010033", "1010035", "1010671", "1010673", "1010688", "1010692", "1010745", "1010749", "1010751", "1010755", "1010759", "1010763", "1010900", "1010902", "1737343", "1737345", "1737562", "1737563", "1737566", "1737567", "1737568", "1737569", "1737570", "1737571", "1737757", "1737758", "1737761", "1737762", "1867938", "1867940", "1867943", "1867944", "1867992", "1867993", "1867996", "1867997", "1868028", "1868029"], "spl_id": ["ea480a68-5927-4278-9deb-2956961da428"], "spl_set_id": ["ba082c2f-64f4-419d-9c88-74f203316e17"], "package_ndc": ["63323-492-04", "63323-492-27", "63323-492-09", "63323-492-57", "63323-492-07", "63323-492-37", "63323-492-03", "63323-492-31", "63323-491-01", "63323-491-57", "63323-495-09", "63323-495-27", "63323-495-04", "63323-495-07", "63323-485-01", "63323-485-27", "63323-485-03", "63323-485-57", "63323-486-01", "63323-486-17", "63323-486-02", "63323-486-27", "63323-486-05", "63323-486-57", "63323-484-57", "63323-489-02", "63323-489-27", "63323-489-03", "63323-489-21", "63323-489-01", "63323-489-17", "63323-488-07", "63323-488-37", "63323-488-03", "63323-488-31", "63323-488-01", "63323-488-17", "63323-481-01", "63323-481-57", "63323-483-03", "63323-483-27", "63323-483-01", "63323-483-57", "63323-482-01", "63323-482-17", "63323-482-03", "63323-482-27", "63323-482-05", "63323-482-57", "63323-487-01", "63323-487-17", "63323-487-07", "63323-487-37", "63323-487-03", "63323-487-31"], "is_original_packager": [true], "upc": ["0363323484576", "0363323485016", "0363323483036", "0363323487072", "0363323486013", "0363323495091", "0363323488079", "0363323489021", "0363323495046", "0363323491017", "0363323492045", "0363323492090", "0363323482015", "0363323481018"], "unii": ["EC2CNF7XFP", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1052-2022", "product_description": "Xylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL, 25-count box (NDC 63323-482-57), Rx only, MFG: Fresenius Kabi USA LLC", "product_quantity": "76 trays/25 vials per tray", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0812-2022", "product_description": "QM-4, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mL . Atropine 0.2 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0020-10.", "product_quantity": "1647 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E41027 BUD: 5/27/2022, I24E13 BUD: 9/13/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1476-2022", "product_description": "MILK OF MAGNESIA USP, 2400 mg/30 mL, Magnesium Hydroxide, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-6846-73.", "product_quantity": "24,400 cups", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot#  20071A, EXP Jul. 2022"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1257-2022", "product_description": "HYDROmorphone HCl Injection, USP 30 mg/30 mL (1 mg/mL) syringe, 5 x 30 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-559-30", "product_quantity": "18,570 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: HN2001A, Exp. 7/23/2022; HN2003A, Exp. 8/19/2022; HN2004A, Exp. 9/9/2022"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0475-2022", "product_description": "MidNite Sleep Health (melatonin 1.5 mg) tablets, 30-count bottles, Distributed by: Mylan Consumer Healthcare, Inc. Morgantown, WV 26505 USA", "product_quantity": "2,189,232 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: 18L124, 18L125, 18L126, Exp. Date 02/2022; 19C037, 19C038, 19C039, 19C040, Exp. Date 03/2022; 19D029, 19D030, Exp. Date 04/2022; 19D031, Exp. Date 06/2022; 19G047, Exp. Date 07/2022"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0734-2022", "product_description": "TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 76681, APS Pharmacy", "product_quantity": "24 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lot: 754381 BUD: 8/1/2022"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1199-2022", "product_description": "Dexpanthenol 250mg/mL, 30mL-vial, Room Temperature, Tailor Made Compounding", "product_quantity": "19 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch #: 01032232A1, Exp 7/2/2022; 01242229A2, Exp 7/23/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206884"], "brand_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "generic_name": ["AMLODIPINE AND OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-190", "33342-191", "33342-192", "33342-193"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "OLMESARTAN MEDOXOMIL"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_id": ["ec147040-b267-4905-b311-09ebce2080b4"], "spl_set_id": ["c86a3c45-c906-46c9-9f7b-6c3d89bbe48f"], "package_ndc": ["33342-190-07", "33342-190-10", "33342-190-12", "33342-190-44", "33342-191-07", "33342-191-10", "33342-191-12", "33342-191-44", "33342-192-07", "33342-192-10", "33342-192-12", "33342-192-44", "33342-193-07", "33342-193-10", "33342-193-12", "33342-193-44"], "is_original_packager": [true], "upc": ["0333342190079", "0333342190109", "0333342191076", "0333342193070", "0333342193100", "0333342192103", "0333342192073", "0333342191106"], "unii": ["6M97XTV3HD", "864V2Q084H"]}, "product_type": "Drugs", "event_id": "89600", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0632-2022", "product_description": "Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.", "product_quantity": "3,672 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220215", "center_classification_date": "20220225", "termination_date": "20230217", "report_date": "20220309", "code_info": "Lot#: BAD62101A, Exp 2/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1424-2022", "product_description": "FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990  GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724   BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438   BAYER LOW DOSE 81 MG TABLET 120 CT SKU 916070   BAYER ASPIRIN 325MG TABLET 24CT SKU 913996   BAYER LOW DOSE TABLET 32CT SKU 915641   BAYER 81MG CHEWABLE TABLET 36 CT SKU 916078 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 913990; 913724; 900438; 916070; 913996; 915641; 916078", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050065"], "brand_name": ["NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE"], "generic_name": ["NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["61314-631"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXAMETHASONE", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE"], "rxcui": ["309679"], "spl_id": ["91b9784c-1234-492b-99b1-dd456ef437b5"], "spl_set_id": ["7f2e3c46-9f39-45e7-99a9-64cc4f6f649d"], "package_ndc": ["61314-631-36"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["7S5I7G3JQL", "057Y626693", "19371312D4"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1102-2022", "product_description": "Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631-36", "product_quantity": "120 tubes", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1239-2022", "product_description": "Testosterone Propionate 100mg/ml, 10mL-vial,  Room temperature, Tailor Made Compounding", "product_quantity": "64 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 12012123A2, Exp 5/30/2022; 01312212A1, Exp 7/30/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0339-2022", "product_description": "H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg/Antihistamine     12 count bottle, Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic, NDC 37808-425-53, UPC  0 41220 53080 9", "product_quantity": "26,304 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot 0JE2491, 0LE2178, Exp 01/31/2022; 0ME2516, Exp 4/30/2022"}, {"status": "Terminated", "city": "Berkeley", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90289", "recalling_firm": "Valor Compounding Pharmacy, Inc DBA  Valor Compounding Pharmacy", "address_1": "2461 Shattuck Ave", "address_2": "", "postal_code": "94704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "CA", "recall_number": "D-1168-2022", "product_description": "Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704", "product_quantity": "950 mLs in 1x8 oz and 2x16 oz bottles.", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20220415", "center_classification_date": "20220627", "termination_date": "20221107", "report_date": "20220615", "code_info": "Lot #: 04272022@35, BUD: 7/7/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89797", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0865-2022", "product_description": "Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 7400 Alumax Road, Texarkana, TX 75501. NDC 0395-8212-56", "product_quantity": "2 containers", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20220304", "center_classification_date": "20220511", "termination_date": "20240714", "report_date": "20220518", "code_info": "Lot #: 18L12-U02-050018, Exp. Date 10/31/2022"}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90682", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 6 distributors/wholesalers who may have further distributed the product.", "recall_number": "D-1353-2022", "product_description": "Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b) 1000-count bottle (NDC 71399-8022-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ", "product_quantity": "30,325 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Imprint \"AP 325\" is missing from the tablet.", "recall_initiation_date": "20220804", "center_classification_date": "20220817", "termination_date": "20231204", "report_date": "20220824", "code_info": "Lot#: AXA2014, Exp Feb-23; AXB2001, Exp Nov-22; AXB2002, AXB2003, AXB2004, AXB2005, AXB2006, AXB2007, AXB2008, AXB2009, AXB2010, AXB2011, Exp Dec-22; AXB2012, AXB2013, AXB2014, AXB2015, AXB2016, AXB2017, AXB2018, AXB2019, AXB2020, AXB2021, AXB2022, AXB2023, AXB2024, AXB2025, AXB2026, AXB2027, Exp Feb-23", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0432-2022", "product_description": "CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC\t05446-1634-01", "product_quantity": "440 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "10-2021-05@9 01-01-2022 & 10-2021-28@4 01-26-2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orangeburg", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021524"], "brand_name": ["PREVANTICS SWAB"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["Professional Disposables International, Inc."], "product_ndc": ["10819-1080"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["1191171", "1366736"], "spl_id": ["079d6f47-65e3-2f14-e063-6394a90a444a", "078de79b-c16c-78f8-e063-6294a90a384a"], "spl_set_id": ["db61e7fd-c421-4e3c-bc88-0343230273de", "ff999b50-0b6b-404e-b4f1-c6694fe47a9b"], "package_ndc": ["10819-1080-1", "10819-1080-2"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "89547", "recalling_firm": "Professional Disposables International, Inc.", "address_1": "2 Nice Pak Park", "address_2": "", "postal_code": "10962-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0571-2022", "product_description": "Prevantics (chlorhexidine gluconate and isopropyl alcohol) Swab, 3.15% w/v and 70% v/v, packaged as a) One Swab, 0.034 fl. Oz. (1 mL) Each in a pouch, 100 Individual Swabs per carton, 10 boxes of 100 Individual Swabs per case, REORDER NO. B10800, NDC 10819-1080-1; b) One Swab, 0.034 fl. oz. (1 mL) Each in a pouch, 3000 Individual Swabs per case, REORDER NO. B11400, NDC 10819-1080-2; Professional Disposables International, Inc., Orangeburg, NY  10962-1376.", "product_quantity": "a) 160531 cases; b) 16123 cases", "reason_for_recall": "cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.", "recall_initiation_date": "20220204", "center_classification_date": "20220218", "termination_date": "20231031", "report_date": "20220302", "code_info": "Lot #: a) 12000165, 12000166, 12000382, Exp Feb 2022; 12000228, 12000381, 12000383, 12000577, 12000578, 12000579, 12000661, 12000662, Exp Mar 2022; 12000659, 12000660, Exp Apr 2022; 12001060, 12001061, 12001062, 12001100 LE, 12001101 LE, Exp Jun 2022;  12001233, 12001234, 12001235, 12001236, Exp Jul 2022; 12001351, 12001394, 12001395, 12001396, 12001397, 12001398, 12001399, Exp Aug 2022; 12001632,12001633, 12001634, 12001635, 12001636, Exp Sep 2022; 12001637, 12001638, 12001639, 12001640, 12001641, 12001721, 12001791, Exp Oct 2022; 12001792, 12001793, 12001794, 12001962, Exp Nov 2022; 12002039, 12002040, 12100014, 12100015, 12100016, 12100017,  12100035, 12100036, 12100037, 12100074, 12100183, 12100184, Exp Jan 2023; 12100018, 12100185, 12100186, 12100192, 12100193, 12100194, 12100195, 12100241, 12100242, 12100243, 12100244, 12100245, 12100246, 12100247, 12100277, Exp Feb 2023; 12100312, 12100313, 12100347, 12100348, 12100349, Exp Mar 2023; 12100350, 12100351, 12100543, 12100638, Exp Apr 2023; 12100541, 12100542, 12100639, 12100732, 12100733, 12100753, 12100754, Exp May 2023; 12100755, 12100790, 12100791, 12100824, Exp Jun 2023; b) 12000194, 12000195, Exp Feb 2022; 12000500, 12000570, 12000594, 12000698, Exp Mar 2022; 12001058, 12001059, 12001069, 12001108 LE, 12001109 LE, 12001110 LE, Exp Jun 2022; 12001111 LE, 12001225, 12001226, 12001227, 12001228, 12001229, 12001230, Exp Jul 2022; 12001393, 12001522, Exp Aug 2022; 12001734, 12001735, 12001736, 12001737, Exp Oct 2022; 12001854, Exp Nov 2022; 12002033, 12002035, 12002045, 12002046, Exp Dec 2022; 12100019, 12100020, 12100021, 12100022, 12100096, 12100097, 12100098, 12100099, Exp Jan 2023; 12100196, 12100197, 12100251, 12100252, 12100253, 12100254, 12100255, 12100256, 12100257, 12100346, Exp Feb 2023; 12100363,12100364, 12100365, 12100366, Exp Mar 2023; 12100518, 12100519, 12100520, 12100521, Exp Apr 2023; 12100691, 12100693, Exp May 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90443", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1175-2022", "product_description": "CVS Health Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Lemon Flavor, 10 FL OZ (296 mL), Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI  02895, UPC 0 50428 30594 2.", "product_quantity": "98,958 bottles", "reason_for_recall": "Microbial Contamination of a Non-Sterile Products: Testing of product  onfirmed the presence of Gluconacetobacter Liquefaciens", "recall_initiation_date": "20220613", "center_classification_date": "20220705", "termination_date": "20240506", "report_date": "20220713", "code_info": "Lot: 0556808 Exp. 12/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1370-2022", "product_description": "SUAVE INV SLD PWDR 1.2 OZ SKU2004504   SUAVE AP INV SOLID SWEET PEA 1.2 OZ\tSKU 2004622   LADY SPEED STICK AP WILD FREESSIA 1.4OZ\t SKU 2005184   SUAVE AP DEOD POWDER 2.6 OZ 2PK SKU 2028126   SCRT IN SLD PWDR FRSH 2.1OZ 2PK SKU 2028363   LADY SPD STK AP INV PWDR 1.4OZ SKU 2028365   DEGREE INV SLD XBLST 2.7 OZ 2PK\tSKU 2028378   SECRET DEO INV SHWR FRSH 2.1 OZ SKU 2028538  SUAVE DEO TRPCL PARADISE 1.2 OZ\tSKU 2028544   SECRET DS WHTE PECH ARGN OIL SPRY 4.1 OZ SKU 2095889   SECRET DS WILD ROSE OIL SPRAY 4.1 OZ SKU 2095896   DOVE ADVANCED COOL ESSENTIALS 2.6OZ SKU 2099968   OLD SPICE RED ZONE DEO SWAGGER 3OZ SKU 2005168   OLD SPICE HE FRESH DEO 2.4OZ 2PK SKU 2007730   SECRET OUTLAST CLEAN LVNDR GEL 2.6OZ SKU 2098900   OLD SPICE WC IS BEARGLOVE 2.6OZ SKU 2099254   DEGREE FMAL BLCK WHT PURERN DRYSPRY3.8OZ SKU 2003471  DEGREE EXTREME BLAST IS 2.7 OZ SKU 2005214   SECRET FRESH IS COCOA BUTTER 2.6OZ SKU 2007898   SECRET OUTLAST IS COMPLETELY CLEAN 2.6OZ SKU 2001333   DEGREE ML INVIS SLD COOL RUSH 1.7OZ SKU 2002557   OLD SPICE RZ SWAGGER 2.6 OZ SKU 2004512   DOVE AP INV SLD FRESH 1.6 OZ SKU 2028253   DEGREE FOR WOMEN IS BW PURE RAIN 2.6 OZ SKU 2096622   DEGREE BLCK WHIT PURE CLN DRY SPRY 3.8 OZ SKU 2003471   DEGREE MEN INV SLD SPORT TWIN  2.7 OZ 2PK SKU 2001309   SECRET INVS SLD PWDR FRSH 2.1 OZ SKU 2028310 \t  DOVE ADVANCED CARE IS COCONUT 2.6 OZ SKU 2006902 \t  SECRET FRESH EXP PARIS ROSE GEL 2.6 OZ SKU 2098479 \t  OLD SPICE FIJI 2.6OZ SKU 2001336   SECRET AP STICK FRSH PWD 1.7OZ\tSKU 2028566   DOVE MEN AP INV SLD XTRA FRSH 2.7 OZ SKU  SECRET OUTLAST CLR GEL PWDR PROTEC 2.6OZ\t SKU 2044343   DOVE CARING COCONUT DRY SPRAY 3.8OZ SKU 2097527   DOVE CLR FNSH  100 CLRS DRY SPR 3.8FLOZ SKU 2098905  AXE AP INV SLD DK TEMPT 2.7OZ SKU 2028222   DOVE DRY SPRAY COOL ESSENTIALS 3.8 OZ L2 SKU 2006098   DEGREE FMLE INV SLD TWN PWDR 2.6 OZ 2PK SKU 2001311   OLD SPICE HE PLAYMAKER 2.4 OZ SKU 2004835   GIL CLEAR GEL COOL WAVE 2.85 OZ 2PK\tSKU 2005220   DEGREE WMNS SEXY INTRIGUE 2.6 OZ SKU 2028194   MENNEN SPEED STCK AP INV SLD FRSH 1.8 OZ SKU 2028249   DOVE INV SLD POWDER 1.6 OZ\tSKU 2028255   DEGREE AP INV SLD XBLAST 1.7 OZ\tSKU 2028257   AH ULTRAMAX INV SLD FRSH SCT 1 OZ SKU 2028315   POWER STICK LADY AP POWDER FRESH 1.7 OZ SKU 2044190 \t  DOVE MENS INV SOLID CLEAN COMFORT 1.7 OZ SKU 2097528   AXE APOLLO INV SOLID DEODORANT 1.7 OZ SKU 2097534   DEGREE AP INV SLD FRESH 2.6OZ SKU 2028218   SUAVE AP INV SLD TRPCL PARDSE 2.6 OZ SKU 2004752   DEGREE AP INV SLD SHOWR 1.6 OZ SKU 2028258   SUAVE MENS ACTIVE SPORT 2.7OZ SKU 2098472   OLD SPICE  INV SLD KRAKENGARD 2.6OZ SKU 2098901   AXE ANARCHY INVISIBLE SOLID 2.7 OZ SKU 2005211   distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown.", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 2098901; 2005211; 2004504; 2004622; 2005184; 2028126; 2028363; 2028365; 2028378; 2028538; 2028544; 2095889; 2095896; 2099968; 2005168; 2007730; 2098900; 2099254; 2003472; 2005214; 2007898; 2001333; 2002557; 2004512; 2028253; 2096622; 2003471; 2001309; 2028310; 2006902; 2098479;  2001336; 2028566 ;  2004735 ;  2044343 ;  2097527 ;  2098905 ;  2028222 ;  2006098 ;  2001311 ;  2004835 ;  2005220 ;  2028194 ;  2028249 ;  2028255 ;  2028257 ;  2028315 ;  2044190 ;  2097528 ;  2097534 ;  2028218 ;  2004752 ;  2028258;  2098472", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["DG HEALTH SINUS SEVERE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Dolgencorp, LLC"], "product_ndc": ["55910-696"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["1bb80c59-6e86-4654-b29c-237c45faa039"], "spl_set_id": ["7abaa912-be8b-463c-8818-104e79b33539"], "package_ndc": ["55910-696-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0627-2022", "product_description": "Sinus Severe, Oxymetazoline HCl 0.05% Nasal Decongestant with Menthol, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY DOLGENCORP, LLC., 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072. NDC 55910-696-10", "product_quantity": "79,776 botles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0931, Exp 12/31/2022; 1CK0900, Exp 01/31/2023; 1HK1196, Exp 02/28/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90152", "recalling_firm": "AMS Packaging Inc", "address_1": "161 Helen St", "address_2": "", "postal_code": "07080-3806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1148-2022", "product_description": "Premium Nature Instant Hand Sanitizer, (ethyl alcohol 65%), 8 oz/ 236 ML plastic bottles;  Premium Nature, South Plainfield, NJ. UPC 819192028668", "product_quantity": "unknown", "reason_for_recall": "Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.", "recall_initiation_date": "20220510", "center_classification_date": "20220614", "report_date": "20220622", "code_info": "all lots", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0409-2022", "product_description": "Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1011-01", "product_quantity": "154 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "11-2021-08@9 12/18/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1426-2022", "product_description": "GC MILK OF MAGNESIA CHERRY 12 FL OZ SKU 915000   GC MILK OF MAGNESIA MINT 12 FL OZ SKU 915623 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 915000; 915623", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0312-2022", "product_description": "Midazolam in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-102-02.", "product_quantity": "36360 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21065/BQA 12-Nov-21  S21066/BQB 19-Nov-21  S21142/BTA 19-Nov-21  S21143/BTB 20-Nov-21  S21146/BTE 21-Nov-21  S21147/BTF 25-Nov-21  S21148/BTG 25-Nov-21  S21153/BTL 26-Nov-21  S21154/BTM 27-Nov-21  S21171/BUC 10-Dec-21  S21172/BUD 11-Dec-21  S21173/BUE 15-Dec-21  S21190/BUT 16-Dec-21  S21201/BVD 22-Dec-21  S21202/BVE 24-Dec-21  S21203/BVF 29-Dec-21  S21204/BVG 19-Jan-22  S21258/BXD 20-Jan-22  S21275/BXS 30-Jan-22  S21276/BXT 2-Feb-22  S21277/BXU 3-Feb-22  S21278/BXV 3-Feb-22  S21284/BYB 4-Feb-22  S21285/BYC 5-Feb-22  S21286/BYD 11-Feb-22  S21287/BYE 12-Feb-22  S21290/BYH 16-Feb-22  S21304/BYT 23-Feb-22  S21306/BYV 24-Feb-22  S21308/BYX 25-Feb-22  S21310/BYZ 26-Feb-22  S21379/CBM 14-Apr-22  S21382/CBP 14-Apr-22  S21385/CBS 15-Apr-22", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90442", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1170-2022", "product_description": "Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only, 60 mL (2 fl. oz.) bottle, Manufactured by: HI-TECH PHARMACAL CO., INC., Amityville, N.Y. 11701.  NDC: 50383-732-02", "product_quantity": "2,736 Bottles", "reason_for_recall": "Defective Delivery System: Potential defect that could prevent the product from dispensing as intended.", "recall_initiation_date": "20220610", "center_classification_date": "20220629", "termination_date": "20230928", "report_date": "20220706", "code_info": "Lot #: 378440, Exp. 07/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091269"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Dr.Reddy's Laboratories Ltd."], "product_ndc": ["55111-398", "55111-399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["311277", "596843"], "spl_id": ["c8eb1d41-1fd2-7c06-486c-e6abf08faa6d"], "spl_set_id": ["82174fcc-1b0f-2068-7fc4-db335b43b5e2"], "package_ndc": ["55111-398-30", "55111-398-60", "55111-398-90", "55111-398-01", "55111-398-05", "55111-398-79", "55111-399-30", "55111-399-60", "55111-399-90", "55111-399-01", "55111-399-05", "55111-399-79"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "89871", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0737-2022", "product_description": "Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India", "product_quantity": "8,352 bottles (30-count), 1,368 bottles (90-count)", "reason_for_recall": "Failed Dissolution Specifications; during long term stability testing.", "recall_initiation_date": "20220323", "center_classification_date": "20220331", "termination_date": "20240202", "report_date": "20220406", "code_info": "Lot # a) C2103093, Exp. 12/2023; b)C2103092, Exp. 12/2023."}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1122-2022", "product_description": "Paracentesis/Thoracentises Tray (10/cs) Rx CRFPED, Lidocaine Hydrochloride USP, 1%, 5mL, Rx only, MFG: Becton Dickinson", "product_quantity": "5 cases", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90430", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1156-2022", "product_description": "Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.", "product_quantity": "4941 bottles", "reason_for_recall": "Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.", "recall_initiation_date": "20220614", "center_classification_date": "20220623", "termination_date": "20230427", "report_date": "20220629", "code_info": "Lot #s: 100022971, Exp. 08/2022; 100022972, Exp. 05/2023; 100028920, Exp. 09/2023", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211445"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Nephron SC Inc."], "product_ndc": ["0487-6232"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["1665459"], "spl_id": ["299550cd-e0b8-3ad3-e063-6294a90a460e"], "spl_set_id": ["ae6c60c0-e88a-45b2-e053-2995a90ac62f"], "package_ndc": ["0487-6232-01"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "90703", "recalling_firm": "Nephron Sc Inc", "address_1": "4500 12th Street Ext", "address_2": "", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1354-2022", "product_description": "Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron Pharmaceutical Corporation 4500 12th Street Extension West Columbia, SV 29172, NDC 0487-6232-01", "product_quantity": "5040 vials", "reason_for_recall": "cGMP Deviations: deviations leading to potential cross-contamination.", "recall_initiation_date": "20220810", "center_classification_date": "20220817", "termination_date": "20240924", "report_date": "20220824", "code_info": "Lot#: 023011 Exp 8/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA006488"], "brand_name": ["XYLOCAINE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-481", "63323-492", "63323-491", "63323-495", "63323-485", "63323-486", "63323-484", "63323-489", "63323-488", "63323-483", "63323-482", "63323-487"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1010033", "1010035", "1010671", "1010673", "1010688", "1010692", "1010745", "1010749", "1010751", "1010755", "1010759", "1010763", "1010900", "1010902", "1737343", "1737345", "1737562", "1737563", "1737566", "1737567", "1737568", "1737569", "1737570", "1737571", "1737757", "1737758", "1737761", "1737762", "1867938", "1867940", "1867943", "1867944", "1867992", "1867993", "1867996", "1867997", "1868028", "1868029"], "spl_id": ["ea480a68-5927-4278-9deb-2956961da428"], "spl_set_id": ["ba082c2f-64f4-419d-9c88-74f203316e17"], "package_ndc": ["63323-492-04", "63323-492-27", "63323-492-09", "63323-492-57", "63323-492-07", "63323-492-37", "63323-492-03", "63323-492-31", "63323-491-01", "63323-491-57", "63323-495-09", "63323-495-27", "63323-495-04", "63323-495-07", "63323-485-01", "63323-485-27", "63323-485-03", "63323-485-57", "63323-486-01", "63323-486-17", "63323-486-02", "63323-486-27", "63323-486-05", "63323-486-57", "63323-484-57", "63323-489-02", "63323-489-27", "63323-489-03", "63323-489-21", "63323-489-01", "63323-489-17", "63323-488-07", "63323-488-37", "63323-488-03", "63323-488-31", "63323-488-01", "63323-488-17", "63323-481-01", "63323-481-57", "63323-483-03", "63323-483-27", "63323-483-01", "63323-483-57", "63323-482-01", "63323-482-17", "63323-482-03", "63323-482-27", "63323-482-05", "63323-482-57", "63323-487-01", "63323-487-17", "63323-487-07", "63323-487-37", "63323-487-03", "63323-487-31"], "is_original_packager": [true], "upc": ["0363323484576", "0363323485016", "0363323483036", "0363323487072", "0363323486013", "0363323495091", "0363323488079", "0363323489021", "0363323495046", "0363323491017", "0363323492045", "0363323492090", "0363323482015", "0363323481018"], "unii": ["EC2CNF7XFP", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1053-2022", "product_description": "Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27", "product_quantity": "33 trays/25 vials per tray", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211406"], "brand_name": ["SIROLIMUS"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-6197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIROLIMUS"], "rxcui": ["314230"], "spl_id": ["5fb6d644-aae8-0bcc-d9ce-170dff1c4b44"], "spl_set_id": ["9f64692d-2a18-ffcb-c572-0f218a71ca67"], "package_ndc": ["60505-6197-2"], "is_original_packager": [true], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "90114", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0881-2022", "product_description": "Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2", "product_quantity": "2353 bottles", "reason_for_recall": "Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.", "recall_initiation_date": "20220503", "center_classification_date": "20220518", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lot: RZ1598, exp. date 02/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1437-2022", "product_description": "BLISTEX LIP MEDEX 0.25OZ SKU 906120   BLISTEX LIP MEDEX POT 0.38 OZ SKU 998852 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 906120; 998852", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0704-2022", "product_description": "Lidocaine Cream 4%, Net Wt. 30 grams tube, Distributed by: RUGBY LABORATORIES, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI  48152, NDC 0536-1281-28.", "product_quantity": "48,907 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15722, Exp. 6/30/2022; 16274, Exp. 12/31/2022; 16947, Exp. 5/31/2023; 17140, Exp. 8/31/2023"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090382"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-933", "64380-934", "64380-935"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["ff308b3c-902c-4149-addb-ec8d5dfbf00c"], "spl_set_id": ["a8817f22-8478-49b9-8354-ab27ca222c6b"], "package_ndc": ["64380-933-04", "64380-933-05", "64380-933-08", "64380-934-04", "64380-934-05", "64380-934-08", "64380-935-04", "64380-935-05", "64380-935-08"], "is_original_packager": [true], "upc": ["0364380933083", "0364380935049", "0364380933045", "0364380934042", "0364380934059", "0364380934080", "0364380933052", "0364380935087", "0364380935056"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "90229", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-0973-2022", "product_description": "Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816.    90 film coated tablets NDC 64380-934-05  1000 film coated tablets NDC 64380-934-08", "product_quantity": "381456 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220518", "center_classification_date": "20220528", "termination_date": "20231020", "report_date": "20220608", "code_info": "NDC 64380-934-05  Lot 7901146A, 7901147A, 7901148A & 7901149A, Exp Date Sep-22; Lot 7901279A, 7901280A, 7901281A, 7901282A, 7901283A & 7901284A, Exp Date Nov-22; Lot 7901359A, 7901360A & 7901361A, Exp Date Dec-22; Lot 7901362A, 7901406A, 7901407A, 7901408A & 7901409A, Exp Date Jan-23.   64380-934-08  Lot 7901008A & 7901009A, Exp Date Jun-22; Lot 7901150A & 7901151A, Exp Date Sep-22; Lot 7901285B, 7901286B, 7901287A, 7901288A, 7901289A, 7901290A, 7901291A, 7901292A, 7901293A & 7901294A, Exp Date Nov-22."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0340-2022", "product_description": "H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine     packaged as a) 15 count bottle, NDC 37808-571-22, UPC 0 41220 53081 6; b)  30 count bottle, NDC 37808-571-39, UPC 0 41220 53082 3; c) 45 count bottle, NDC 37808-571-95, UPC 0 41220 53083 0; Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic,", "product_quantity": "13,920 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot a) 0HE2530, Exp 12/31/2021;  0JE2407, Exp 2/28/2022: b) 1BR0462, Exp 10/31/2022 c) 0FR0460, Exp 2/28/2022: 0LR0363, Exp 6/30/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208135"], "brand_name": ["TETRACAINE HYDROCHLORIDE"], "generic_name": ["TETRACAINE HYDROCHLORIDE"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0741"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TETRACAINE HYDROCHLORIDE"], "rxcui": ["1547771"], "spl_id": ["e5c0f202-3d32-4b47-8d45-e1d031ff7ce9"], "spl_set_id": ["5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79"], "package_ndc": ["0065-0741-12", "0065-0741-14"], "is_original_packager": [true], "upc": ["0300650741149"], "unii": ["5NF5D4OPCI"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1113-2022", "product_description": "Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottle, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0741-14", "product_quantity": "43 cartons/12 blister packs", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076447"], "brand_name": ["CAREONE ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HCL"], "manufacturer_name": ["American Sales Company"], "product_ndc": ["41520-229"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["57501f04-ba3d-4e21-af64-60674a4c9256"], "spl_set_id": ["65720e72-c20d-4363-92ab-76596e043bc0"], "package_ndc": ["41520-229-95", "41520-229-39", "41520-229-22"], "is_original_packager": [true], "unii": ["2S068B75ZU"], "upc": ["341520319846", "341520319839"]}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0334-2022", "product_description": "CAREONE Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine,  24HR, packaged as a)30 count bottle, NDC 41520-229-39, UPC 3 41520 31984 6;  b)45 count bottle, NDC 41520-229-95 UPC 3 41520 31983 9; Made in the Czech Republic, Distributed by: Foodhold U.S.A. LLC Landover, MD 20785. Made in Czech Republic", "product_quantity": "28776 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot a) 0FR0459, Exp 2/28/2022; 0LR0362, Exp 6/30/2022; 1BR0462, Exp 10/31/2022 b) 0LR0363, Exp 6/30/2022"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["SINUS PRESSURE, PAIN AND COUGH"], "generic_name": ["ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL"], "manufacturer_name": ["Walgreen Company"], "product_ndc": ["0363-6171"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1110988"], "spl_id": ["f2cc7da1-4d7a-4ecf-ab64-fe8889ae9630"], "spl_set_id": ["97554f40-f9aa-4dbf-a6f2-de6197236ab4"], "package_ndc": ["0363-6171-09"], "is_original_packager": [true], "upc": ["0311917009476"], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "90983", "recalling_firm": "LNK International, Inc.", "address_1": "55 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0014-2023", "product_description": "NDC 0363-6171-09 Walgreens Sinus Pressure, Pain & Cough  ACETAMINOPHEN/ PAIN RELIEVER DEXTROMETHORPHAN HBr/ COUGH SUPPRESSANT GUAIFENESIN/ EXPECTORANT PHENYLEPHRINE HCl/ NASAL DECONGESTANT Maximum Strength    Decongestant Free DISTRIBUTED BY: WALGREENS CO. 200 WILMOT RD., DEERFIELD, IL 60015 walgreens.com", "product_quantity": "66,384 boxes of twenty tablets each", "reason_for_recall": "Boxes mislabeled to read \"Decongestant Free\", but the product contains Phenylephrine HCI 5mg", "recall_initiation_date": "20221011", "center_classification_date": "20221018", "termination_date": "20230725", "report_date": "20221026", "code_info": "P129910   P129911   P130240", "more_code_info": ""}, {"status": "Completed", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086413"], "brand_name": ["TRIAMCINOLONE ACETONIDE"], "generic_name": ["TRIAMCINOLONE ACETONIDE CREAM"], "manufacturer_name": ["Direct Rx"], "product_ndc": ["72189-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TRIAMCINOLONE ACETONIDE"], "rxcui": ["1014314"], "spl_id": ["2c3d5768-7eac-50ff-e063-6394a90afae0"], "spl_set_id": ["d92e9eaf-3a79-76d7-e053-2995a90ae28d"], "package_ndc": ["72189-330-80"], "original_packager_product_ndc": ["45802-064"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["F446C597KA"]}, "product_type": "Drugs", "event_id": "90869", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Physicians and Medical Facilities in GA and ID", "recall_number": "D-1535-2022", "product_description": "Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534, Dist. By Perrigo, Allegan, MI 49010, NDC 72189-330-80.", "product_quantity": "20 tubes", "reason_for_recall": "CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.", "recall_initiation_date": "20220912", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lot: 12JY2216, Exp. 2/29/24", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0508-2022", "product_description": "Nutralox Mint Antacid (calcium carbonate 420mg) Chewable tablets,  2-count packets, Manufactured for: HARTHealth Seattle, WA 98124", "product_quantity": "1,486,050 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9566, Exp. Date 04/2022; AK9612, Exp. Date 05/2022"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90270", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "N/A", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0977-2022", "product_description": "AMBI Skincare Fade Cream Oily Skin New & Improved, Net Wt. 2 OZ (56g)", "product_quantity": "N/A", "reason_for_recall": "cGMP deviations: product stored outside of labeled temperature requirements.", "recall_initiation_date": "20220517", "center_classification_date": "20220531", "report_date": "20220608", "code_info": "SKUs 2024219"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89560", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0716-2022", "product_description": "Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.", "product_quantity": "11040 tubes", "reason_for_recall": "Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.", "recall_initiation_date": "20220207", "center_classification_date": "20220324", "termination_date": "20240509", "report_date": "20220223", "code_info": "Lot: 15724, Exp. 06/2022"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0492-2022", "product_description": "PAINAID (acetaminophen 110 mg, aspirin 162mg, caffeine 32.4 mg, salicylamide 152mg) 2 tablet packets, Dist. by ZEE Medical Distributors, LLC Mason, OH 45040", "product_quantity": "2,336,600 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9433, Exp. Date 01/2022; AK9749, Exp. Date 08/2022"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["INFANTS PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Kroger Company"], "product_ndc": ["30142-766"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["2a7339bd-2db6-45a5-bbe0-cf55df3154fd"], "spl_set_id": ["7dbe284a-c0d5-4ac4-8445-611610f3c0fb"], "package_ndc": ["30142-766-16"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0596-2022", "product_description": "Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) per bottle, DISTRIBUTED BY THE KROGER CO., CINCINNATI, OHIO 45202.  NDC: 30142-766-16", "product_quantity": "5,184 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK1274, Exp 02/28/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood Cliffs", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89902", "recalling_firm": "Unilever United States Inc.", "address_1": "700 Sylvan Ave", "address_2": "", "postal_code": "07632-3113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0211-2024", "product_description": "Suave 24-Hour Protection Aerosol Antiperspirant Fresh scent, Aluminum Chlorohydrate (19.1%), packaged in 6 oz. cans, Unilever, Dist. By Unilever, Trumbull, CT 06611  UPC 0 79400 78550 3", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20220330", "center_classification_date": "20231228", "report_date": "20220504", "code_info": "all lots, expiry 9/30/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1401-2022", "product_description": "JET ALERT TABLET 30 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 914001", "more_code_info": ""}, {"status": "Ongoing", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA204494"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-997"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1010878"], "spl_id": ["0b1800c4-84d7-4c41-acf3-5f3e8f2e2a8c"], "spl_set_id": ["903cd7bd-6c3d-4068-bb24-e91b1ca1393d"], "package_ndc": ["63739-997-64"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "89135", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to a wholesaler in CO who further distributed Nationwide in the USA", "recall_number": "D-0295-2022", "product_description": "Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64", "product_quantity": "6,816 bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20211130", "center_classification_date": "20211228", "report_date": "20220105", "code_info": "Lot #: 16345, Exp. Date 01/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0701-2022", "product_description": "Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured by: Teligent Pharm, Inc., Buena, New Jersey 08310, NDC 52565-063-60.", "product_quantity": "4532 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15876, Exp 8/31/2022; 16205, Exp. 11/30/2022"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204037"], "brand_name": ["OXYCODONE HYDROCHLORIDE"], "generic_name": ["OXYCODONE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-406"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYCODONE HYDROCHLORIDE"], "rxcui": ["1049604"], "spl_id": ["30ca5ab4-1e96-888b-e063-6294a90abae0"], "spl_set_id": ["0a6b0659-6816-4f44-81bd-9bac4da5380d"], "package_ndc": ["60687-406-40", "60687-406-46", "60687-406-77", "60687-406-67"], "original_packager_product_ndc": ["0054-0390"], "unii": ["C1ENJ2TE6C"]}, "product_type": "Drugs", "event_id": "89670", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0652-2022", "product_description": "Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10 Cups, Rx Only, For Institutional Use Only, American Health Packaging, Columbus, OH 43217.  UPC (01) 003 60687 406 40 4; Case NDC#: 60687-406-77, Unit Dose NDC#: 60687-406-40", "product_quantity": "89,880 unit-dose cups", "reason_for_recall": "Impurity failure at 0-time of the repackaged lot.", "recall_initiation_date": "20220222", "center_classification_date": "20220311", "termination_date": "20230716", "report_date": "20220316", "code_info": "Lot#  1004276, Exp 11/30/2022"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M007"], "brand_name": ["CITROMA"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["Vi-Jon, LLC"], "product_ndc": ["0869-0166"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760", "1245168"], "spl_id": ["32bff861-0e5b-19ba-e063-6294a90a3103"], "spl_set_id": ["fe2c8d20-c3c4-4032-9a6c-246060badcc5"], "package_ndc": ["0869-0166-38"], "is_original_packager": [true], "upc": ["0072785143883", "072785134058"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1507-2022", "product_description": "SWAN, Citroma MAGNESIUM CITRATE, Saline Laxative, Oral Solution, (1.745 g/fl oz), Lemony Flavor, 10 FL OZ (296 mL), Distributed by: Vi-Jon, Inc. One Swan Drive Smyrna, TN 37167; NDC 0869-0166-38 UPC 0 72785 13405 8", "product_quantity": "27,612 bottles", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot # 0562243, EXP 2/17/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1051-2022", "product_description": "Glucagon Emergency Kit  for Low Blood Sugar, Glucagon for Injection, 1 mg per vial Diluent for Glucagon, 1ml syringe, Rx only, MFG: Eli Lilly, NDC 0002-8031-01", "product_quantity": "13 syringes", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0320-2022", "product_description": "NOREPINEPHRINE, 4 mg per 250 mL, (18 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-651-01.", "product_quantity": "121,584 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S20415/BKY 12-Nov-21  S20418/BLB 13-Nov-21  S20452/BMI 5-Dec-21  S20463/BMT 9-Dec-21  S20464/BMU 18-Dec-21  S20478/BNF 23-Dec-21  S21021/BOI 6-Jan-22  S21033/BOU 20-Jan-22  S21047/BPH 21-Jan-22  S21059/BPU 28-Jan-22  S21094/BRE 18-Feb-22  S21117/BSB 3-Mar-22  S21118/BSC 10-Mar-22  S21138/BSW 17-Mar-22  S21227/BWA 7-May-22  S21239/BWK 12-May-22  S21279/BXW 5-Jun-22  S21295/BYL 16-Jun-22  S21298/BYO 18-Jun-22  S21339/BZZ 16-Jul-22  S21346/CAF 21-Jul-22  S21355/CAO 28-Jul-22  S21370/CBD 4-Aug-22  S21372/CBF 7-Aug-22  S21438/CDS 4-Sep-22", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-050", "33342-051", "33342-052"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["cf31d31e-9355-47da-9c2b-8e4b84ac8159"], "spl_set_id": ["a04b5622-2c49-4d61-92b1-5dc523af7a24"], "package_ndc": ["33342-050-07", "33342-050-10", "33342-050-44", "33342-050-12", "33342-051-07", "33342-051-10", "33342-051-44", "33342-051-12", "33342-052-07", "33342-052-10", "33342-052-44", "33342-052-12"], "is_original_packager": [true], "upc": ["0333342051448", "0333342050106", "0333342052100", "0333342051103", "0333342052445", "0333342051073", "0333342052070"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "90037", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0836-2022", "product_description": "Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10)  c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220415", "center_classification_date": "20220503", "termination_date": "20231013", "report_date": "20220511", "code_info": "Lot #   BLM2106B, exp. date 05/2023  BLM2101A, exp. date 01/2025  BLM2102A, exp. date 02/2023  BLM2106A, exp. date 05/2023  BLM2103B, exp. date 02/2023  BLM2104A, exp. date 05/2023  BLM2110A, exp. date 06/2023"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018140"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6044", "0641-6046", "0641-6045", "0641-6047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["LORAZEPAM"], "rxcui": ["238100", "238101", "1665188", "1665326"], "spl_id": ["7c73dbc6-2623-4443-9b05-97dec7a0be2e"], "spl_set_id": ["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"], "package_ndc": ["0641-6044-01", "0641-6044-25", "0641-6046-01", "0641-6046-10", "0641-6045-01", "0641-6045-25", "0641-6047-01", "0641-6047-10"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "90583", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1310-2022", "product_description": "Lorazepam Injection, USP, 4mg/mL, 1 mL vial,  25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# NDC# 0641-6045-25, Vial NDC# 0641-6045-01", "product_quantity": "82,700 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.", "recall_initiation_date": "20220711", "center_classification_date": "20220805", "termination_date": "20230914", "report_date": "20220817", "code_info": "Lot # 070096, exp. date 07/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89361", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0460-2022", "product_description": "Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.", "product_quantity": "31,510 ampules", "reason_for_recall": "Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.", "recall_initiation_date": "20220105", "center_classification_date": "20220127", "termination_date": "20220917", "report_date": "20220119", "code_info": "Lot # 031489A, Expiration 03/31/2022"}, {"status": "Terminated", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90756", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Naionwide within the United States", "recall_number": "D-1463-2022", "product_description": "Maxim Instant Foam Hand Sanitizer (benzalkonium chloride 0.1%) packaged in a) 1 U.S. Gallon (3.78 Liters) drums UPC 7 61841 02502 6 and b) 55 U.S. Gallon drums (208 Liters) UPC 0 07 61841 02504 0, Midlab 140 Private Brand Way, Athens, TN 37303", "product_quantity": "892 gallons and one 55-gallon drum", "reason_for_recall": "CGMP Deviations: Product manufactured using expired active ingredient, Benzalkonium chloride.", "recall_initiation_date": "20220808", "center_classification_date": "20220825", "termination_date": "20230815", "report_date": "20220831", "code_info": "Lot #: a) 03292022-1, 05092022-1, 02012022-1, 06172022-1, 12132021-1, 07272022-1, and b) 06252022-1", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90134", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalled product was distributed to Florida.", "recall_number": "D-0885-2022", "product_description": "Losartan HCTZ 50/12.5 mg, 90 count bottle  Original NDC# 33342-0050-10  Repackaged NDC# 70518-3231-00", "product_quantity": "22 bottles/90 count each", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220504", "center_classification_date": "20220520", "termination_date": "20220902", "report_date": "20220601", "code_info": "Lot #  B1377711-100521, exp. date 10/31/2022  B1412137-102621, exp. date 10/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0824-2022", "product_description": "Testosterone Cypionate 200 mg/mL, (in Sesame Oil), Packaged in a) 10 mL Multi-Dose vial, NDC 73198-0055-10; b) 5 mL Multi-Dose vial, NDC 73198-0055-05, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "3962 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) E48019 BUD: 5/19/2022, F42109 BUD: 6/9/2022, F42C09 BUD: 6/9/2022, G47012 BUD: 7/12/2022, G47112 BUD: 7/12/2022; b) F42B09 BUD: 6/9/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020825"], "brand_name": ["GEODON"], "generic_name": ["ZIPRASIDONE HYDROCHLORIDE"], "manufacturer_name": ["ROERIG"], "product_ndc": ["0049-0056", "0049-3960", "0049-3980", "0049-3990", "0049-3920", "0049-0052", "0049-0054", "0049-0058", "0049-0352", "0049-0354", "0049-0356", "0049-0358"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZIPRASIDONE HYDROCHLORIDE"], "rxcui": ["284548", "284549", "284550", "285127", "313776", "313777", "313778", "314286", "351223", "352228"], "spl_id": ["d3a9a678-f1c3-4883-92eb-5dbe77aa6464"], "spl_set_id": ["8326928a-2cb6-4f7f-9712-03a425a14c37"], "package_ndc": ["0049-3960-60", "0049-3980-60", "0049-3990-60", "0049-3920-20", "0049-3920-83", "0049-3920-01", "0049-3920-10", "0049-0052-60", "0049-0054-60", "0049-0056-60", "0049-0058-60", "0049-0352-60", "0049-0354-60", "0049-0356-60", "0049-0358-60"], "is_original_packager": [true], "upc": ["0300490056601", "0300490058605", "3304023990605", "0300490354608", "3304023960608", "0300490352604", "0300490054607", "0300490052603", "0300490356602", "0300490358606", "3304023980606"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["216X081ORU", "3X6SAX83JZ", "6UKA5VEJ6X"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1112-2022", "product_description": "Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83", "product_quantity": "1 carton/10 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0420-2022", "product_description": "Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL per dropper, Multiple Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Colchester, VT 05446, NDC 05446-0815-01", "product_quantity": "363 droptainers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "09-2021-15@1 12/28/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89986", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States including Guam and the Northern Mariana Islands.", "recall_number": "D-0847-2022", "product_description": "Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-998-67", "product_quantity": "13, 200 tubes", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.", "recall_initiation_date": "20220421", "center_classification_date": "20220505", "report_date": "20220511", "code_info": "Lots: 15720, Exp.: 06/30/2022; 16449 Exp.: 02/28/2023; 16450, Exp.: 02/26/2023"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-101", "49502-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["b526b53a-fe41-462e-b453-745f36d136eb"], "spl_set_id": ["778ac6ae-6bcb-47a4-bcb3-8dd0da9f8836"], "package_ndc": ["49502-102-01", "49502-102-02", "49502-101-01", "49502-101-02"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1014-2022", "product_description": "Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma  NDC 49502-101-02", "product_quantity": "30 packs", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90270", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "N/A", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0975-2022", "product_description": "Only At Family Dollar AMBI Skincare Even & Clear Nourishing Daily Facial Moisturizer With Broad Spectrum SPF 30 Sunscreen, Net Wt. 1.7 FL. OZ. (50 mL)", "product_quantity": "Unknown", "reason_for_recall": "cGMP deviations: product stored outside of labeled temperature requirements.", "recall_initiation_date": "20220517", "center_classification_date": "20220531", "report_date": "20220608", "code_info": "SKUs 2096628."}, {"status": "Terminated", "city": "Fort Myers", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89356", "recalling_firm": "Medique Products", "address_1": "17080 Alico Commerce Ct Ste 1", "address_2": "N/A", "postal_code": "33967-8509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0389-2022", "product_description": "Physicians CARE Extra Strength PAIN RELIEVER [Acetaminophen, Aspirin (NSAID), and Caffeine], 250 mg, 250 mg, 65 mg, packaged as 100-count Tablets (50 Packets, 2 tablets each) per carton, Manufactured for: Acme United Corporation 55 Walls Dr, Fairfield, CT 06824, UPC 0 73577 90316 6", "product_quantity": "3,260,400 tablets", "reason_for_recall": "CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.", "recall_initiation_date": "20211206", "center_classification_date": "20220120", "termination_date": "20230621", "report_date": "20220126", "code_info": "Lots: (Packet, Carton) 6151, 4360 Exp. 10/2021; 6240, 4446 Exp. 12/2021; 6331, 4484 Exp. 02/2022; 6413, 4551 Exp. 04/2022; 6699, 4679 Exp. 10/2022; 6751, 4714 Exp. 12/2022; 6855, 4750 Exp. 01/2023; 6868, 4761 Exp. 02/2023; 6899, 4776 Exp. 02/2023; 6899, 4776 Exp. 02/2023; 7061, 4821 Exp. 05/2023."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0604-2022", "product_description": "Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, Packaged by Perrigo Company for: Big Lots Stores, Inc., P.O. Box 28523, Columbus, OH 43228-0523. NDC: 50594-719-10", "product_quantity": "3,168 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0827, Exp 12/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0691-2022", "product_description": "Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-998-67.", "product_quantity": "21,323 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15720, Exp. 6/30/2022; 16449, 16450, Exp. 2/28/2023"}, {"status": "Terminated", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077060"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-035", "72578-036"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["ca52a4c2-f8fd-4395-a307-3c1ec9c3cf7f"], "spl_set_id": ["85027e6c-d35b-49eb-a234-dd71aa77aee0"], "package_ndc": ["72578-035-01", "72578-035-05", "72578-036-01", "72578-036-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "89305", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 17 wholesalers who further distributed the product to 85 locations.", "recall_number": "D-0392-2022", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles  NDC# 72578-036-01", "product_quantity": "23,8416/100 count bottles", "reason_for_recall": "CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.", "recall_initiation_date": "20211227", "center_classification_date": "20220121", "termination_date": "20230920", "report_date": "20220202", "code_info": "M008130 06/2022,  M008131 06/2022,  M008132 06/2022,  M008133 06/2022,  M010080 07/2022,  M010081 07/2022,  M011029 08/2022,  M011030 08/2022,  M011031 08/2022,  M011032 08/2022,  M011304 08/2022,  M013394 09/2022,  M013395 09/2022,  M013396 09/2022,  M013966 09/2022,  M013967 09/2022,  M100831 12/2022,  M100832 12/2022,  M100833 01/2023,  M100834 01/2023,  M101267 01/2023,  M102718 01/2023,  M102719 01/2023", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208412"], "brand_name": ["PREDNISONE"], "generic_name": ["PREDNISONE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-784", "64380-785", "64380-949"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREDNISONE"], "rxcui": ["198145", "198148", "312615"], "spl_id": ["ea86ffae-1e63-4b4d-9069-696afcc83948"], "spl_set_id": ["2ef05381-faad-4e0f-b58d-9f2236a04a2c"], "package_ndc": ["64380-784-01", "64380-784-07", "64380-784-08", "64380-784-06", "64380-785-06", "64380-785-07", "64380-785-08", "64380-785-01", "64380-949-06", "64380-949-01"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["VB0R961HZT"]}, "product_type": "Drugs", "event_id": "90634", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-1330-2022", "product_description": "Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.", "product_quantity": "1032 bottles", "reason_for_recall": "Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets", "recall_initiation_date": "20220719", "center_classification_date": "20220809", "termination_date": "20230621", "report_date": "20220817", "code_info": "Lot #: 7248988B, Exp 9/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211776"], "brand_name": ["DIFLUPREDNATE"], "generic_name": ["DIFLUPREDNATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-341"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DIFLUPREDNATE"], "rxcui": ["804544"], "spl_id": ["825a55a7-ffdf-4fde-bbb2-486cbd16e602"], "spl_set_id": ["8a7254de-a7a2-476d-9295-c41926267ec9"], "package_ndc": ["69097-341-35"], "is_original_packager": [true], "unii": ["S8A06QG2QE"]}, "product_type": "Drugs", "event_id": "90702", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1328-2022", "product_description": "Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.", "product_quantity": "7,992 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Complaints received of defective container closure.", "recall_initiation_date": "20220802", "center_classification_date": "20220805", "termination_date": "20231127", "report_date": "20220817", "code_info": "Lot # DEG3LC2, Exp 05/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90992", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0012-2023", "product_description": "Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA, NDC 51407-322-30", "product_quantity": "N/A", "reason_for_recall": "Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).", "recall_initiation_date": "20221006", "center_classification_date": "20221017", "termination_date": "20250319", "report_date": "20221026", "code_info": "Lot #: GS036715, GS037569, GS038132, GS038665, GS038750, GS039565, GS039997, GS040673, Exp 10/31/2022; GS040674, GS041237, GS041652, GS042152, GS043365, Exp 3/31/2023; GS045441, GS045677, GS046111, Exp 2/29/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211776"], "brand_name": ["DIFLUPREDNATE"], "generic_name": ["DIFLUPREDNATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-341"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DIFLUPREDNATE"], "rxcui": ["804544"], "spl_id": ["825a55a7-ffdf-4fde-bbb2-486cbd16e602"], "spl_set_id": ["8a7254de-a7a2-476d-9295-c41926267ec9"], "package_ndc": ["69097-341-35"], "is_original_packager": [true], "unii": ["S8A06QG2QE"]}, "product_type": "Drugs", "event_id": "90796", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1499-2022", "product_description": "Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.", "product_quantity": "117,844 bottles", "reason_for_recall": "Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.", "recall_initiation_date": "20220822", "center_classification_date": "20220907", "termination_date": "20231127", "report_date": "20220914", "code_info": "Lot #: DEG1HC2, DEG2HC2, DEG3HC2, DEG4HC2, DEG5HC2, DEG6HC2, Exp 01/2023; DEG1IC2,   DEG2IC2, DEG3IC2, DEG4IC2, Exp 02/2023; DEG1LC2, DEG2LC2, Exp 05/2023; DEG1BD2, DEG2BD2, DEG3BD2, Exp 07/2023"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1246-2022", "product_description": "Atropine Sulfate Injection, USP 1.2 mg/3 mL (0.4 mg/mL) syringe, packaged in 5 x 3 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-935-03", "product_quantity": "13,340 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: AS2001A, Exp. 8/2/2022; AS2002A, Exp. 8/17/2022; AS2003A, Exp. 9/3/2022."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078597"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-796", "62756-797", "62756-798"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099625", "1099678", "1099870"], "spl_id": ["044ee7fd-d980-4b48-b2b7-aa1717e44638"], "spl_set_id": ["64797788-fdcb-4d12-a1a4-743ad71bd17b"], "package_ndc": ["62756-796-83", "62756-796-88", "62756-796-08", "62756-796-13", "62756-796-18", "62756-797-83", "62756-797-88", "62756-797-08", "62756-797-13", "62756-797-18", "62756-798-83", "62756-798-88", "62756-798-08", "62756-798-13", "62756-798-18"], "is_original_packager": [true], "upc": ["0362756796836", "0362756798830"], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "90495", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1291-2022", "product_description": "Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India,  NDC 62756-798-88.", "product_quantity": "9552 bottles", "reason_for_recall": "Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.", "recall_initiation_date": "20220627", "center_classification_date": "20220726", "termination_date": "20230531", "report_date": "20220803", "code_info": "Lot: HAC1312A, EXP. 05/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1195-2022", "product_description": "Ascorbic Acid 500mg/mL, a) 25 ml-vial, b) 50 ml-vial, Refrigerate, Tailor Made Compounding", "product_quantity": "657 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch #: a) 02282223A1, Exp 8/27/2022; 10112101A2, Exp 4/9/2022; 11032108A1, Exp 4/30/2022; 11222101A2, Exp 5/21/2022; b) 01042234B, Exp 7/3/2022; 01242211A2, Exp 7/23/2022; 02282222A1, Exp 8/27/2022; 10112101A2, Exp 4/9/2022; 10182101A1, Exp 4/16/2022; 11162112A1, Exp 5/15/2022; 12062105A2, Exp 6/4/2022; 12142143A2, Exp 6/12/2022; 12202102A2, Exp 6/18/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0325-2022", "product_description": "Sodium Bicarbonate in 5% Dextrose Injection, Rx Only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-326-03", "product_quantity": "2886 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S20459/BMP 17-Nov-21  S20472/BMZ 18-Nov-21  S20473/BNA 18-Nov-21", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0926-2022", "product_description": "Folic Acid 1 mg/mL Hydroxocobalamin 1 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0112-30", "product_quantity": "2441 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24007 BUD: 6/7/2022; B24017-22 BUD: 8/17/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020213"], "brand_name": ["MIOCHOL E"], "generic_name": ["ACETYLCHOLINE CHLORIDE"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "product_ndc": ["24208-539"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["876551", "876553"], "spl_id": ["19c42ee4-9f98-48da-85ea-52090070c2e2"], "spl_set_id": ["e701ef07-9499-4b56-931f-f4eb3eedbe24"], "package_ndc": ["24208-539-20"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0994-2022", "product_description": "Miocol-E (acetylcholine chloride intraocular solution) 20 mg/2mL (10 mg/mL), Rx only, Manufacturer: Bausch & Lomb, NDC 24208-539-20", "product_quantity": "45 kits", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.     The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL"], "generic_name": ["OXYMETAZOLINE HCL"], "manufacturer_name": ["Meijer Distribution Inc"], "product_ndc": ["41250-388"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["d8626005-e7bc-47b2-9c1e-763f35873bf1"], "spl_set_id": ["3984cbc3-b60c-40a7-bc3a-7d1f600503ac"], "package_ndc": ["41250-388-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0619-2022", "product_description": "Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle,  DIST. BY MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544. NDC 41250-388-10", "product_quantity": "10,800 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1FK1164, Exp 01/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020612"], "brand_name": ["LIDOCAINE"], "generic_name": ["LIDOCAINE"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["0603-1880"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["CUTANEOUS"], "substance_name": ["LIDOCAINE"], "rxcui": ["1745091"], "spl_id": ["671190d5-5921-4819-b2e3-8bcf3774d540"], "spl_set_id": ["2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc"], "package_ndc": ["0603-1880-10", "0603-1880-16"], "is_original_packager": [true], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1043-2022", "product_description": "Lidocaine Patch 5%, 30-count carton, Rx only, MFG: Qualitest Products, NDC 0603-1880-16", "product_quantity": "3 cartons/30 pouches per carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPIPEN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-500", "49502-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "727347", "727386", "1870207"], "spl_id": ["81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b"], "spl_set_id": ["7560c201-9246-487c-a13b-6295db04274a"], "package_ndc": ["49502-500-01", "49502-500-02", "49502-500-92", "49502-501-01", "49502-501-02", "49502-501-92"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1012-2022", "product_description": "EPI-Pen Jr, 2-PAK, (epinephrine injection, USP) Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-501-02", "product_quantity": "4 cartons/2 auto injectors each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1526-2022", "product_description": "TRI-MIX 30/1/10 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "16 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lots: 06282022@1, BUD: 08/27/2022; 06292022@8, BUD: 08/28/2022; 07012022@19, BUD: 08/30/2022; 07012022@3, BUD: 08/30/2022; 07122022@8, BUD: 09/10/2022; 07132022@9, BUD: 09/11/2022; 07192022@1, BUD: 09/17/2022; 07292022@9, BUD: 09/27/2022; 08032022@10, BUD: 10/02/2022; 08092022@2, BUD: 10/08/2022; 08102022@1, 08102022@6, 08102022@7, BUD: 10/09/2022; 08152022@5, BUD: 10/14/2022; 08192022@1, 08192022@10, BUD: 10/18/2022", "more_code_info": ""}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1532-2022", "product_description": "TRI-MIX 50/2.5/25 Injectable, 2 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lot: 07052022@2, BUD: 09/03/2022", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207719"], "brand_name": ["PHYTONADIONE"], "generic_name": ["PHYTONADIONE"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-405"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["PHYTONADIONE"], "rxcui": ["1670192"], "spl_id": ["c4a2bf44-0ad2-c0d2-164f-562ba6df930c"], "spl_set_id": ["02445c07-7b4b-cd70-54e8-ebefc814f547"], "package_ndc": ["43598-405-11", "43598-405-16"], "is_original_packager": [true], "nui": ["N0000175965", "N0000175982", "M0022806", "N0000180191", "N0000175966"], "pharm_class_pe": ["Increased Prothrombin Activity [PE]", "Reversed Anticoagulation Activity [PE]"], "pharm_class_cs": ["Vitamin K [CS]"], "pharm_class_epc": ["Vitamin K [EPC]", "Warfarin Reversal Agent [EPC]"], "unii": ["A034SE7857"]}, "product_type": "Drugs", "event_id": "90868", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0007-2023", "product_description": "Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-405-16", "product_quantity": "2,838 ampules", "reason_for_recall": "Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.", "recall_initiation_date": "20220914", "center_classification_date": "20221006", "report_date": "20221012", "code_info": "Lot # ACB101, Exp 03/2023"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0950-2022", "product_description": "8.4% Sodium Bicarbonate Injection, USP, 1 mEq/mL, 4.2 g/50 mL (84 mg/mL), 1 x 50 mL Pre-Filled Syringe, packaged in a) 10 x 1 syringe carton, b) 30 x 1 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-214-50", "product_quantity": "13612 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: SB2001A, Exp. 1/2/2023; SB2005B, SB2005C, Exp. 3/8/2023; SB2006A, SB2006B, SB2006C, Exp. 3/16/2023"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL DECONGESTANT"], "generic_name": ["OXYMETAZOLINE HCL"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6761"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["f62258ce-6b2a-4986-b7d6-20d792e8fde5"], "spl_set_id": ["72b91ce9-6394-4098-90e9-1aba1480cacb"], "package_ndc": ["0904-6761-30"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0618-2022", "product_description": "Soothing 12 Hour Nasal Decongestant Spray No Drip, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,  Distributed By MAJOR PHARMACEUTICALS, 17177 N Laurel Park Drive, Suite 233 Livonia, MI 48152. NDC 0904-6761-30", "product_quantity": "41,472 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0826, Exp 12/31/2022; 1FK1164, Exp 01/31/2023", "more_code_info": ""}]